Phase Ii Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas: A Gynecologic Oncology Group Study
AuthID
P-00V-T45
P-00V-T45
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service